Skip to main content

Clague Laura

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Clague Laura as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TVTX Travere Therapeutics, Inc.

Chief Financial Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 12, 2022 (view filing)May 10-112 daysClague LauraChief Financial OfficerSSale−2.20K$21.51−$47.3K−5.8%35.7K after2 lots
Feb 2, 2022 (view filing)Jan 312 daysClague LauraChief Financial OfficerSSale−1.24K$27.40−$33.9K−3.2%37.9K after
Jan 26, 2022 (view filing)Jan 242 daysClague LauraChief Financial OfficerSSale−2.06K$24.98−$51.5K−6.6%29.3K after
Jan 12, 2022 (view filing)Jan 111 dayClague LauraChief Financial OfficerSSale−7.50K$27.40−$205.5K−19.3%31.3K after
Aug 17, 2021 (view filing)Aug 17Same dayClague LauraChief Financial OfficerSSale−1.41K$17.12−$24.1K−4.3%31.3K after

GNSS Genasys Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 24, 2022 (view filing)Feb 231 dayClague LauraDirectorSSale−13.7K$3.14−$43.1K−6.3%204.3K after